Clinical Trial Update: Study Evaluating EAA-090 in Adult Outpatients With Neuropathic Pain Associated With Diabetic Neuropathy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating EAA-090 for neuropathic pain in adults with diabetic neuropathy was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Diabetic Neuropathy
• Painful Diabetic Neuropathy

Drugs mentioned

• EAA-090

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Diabetes Mellitus, Diabetic Neuropathy, Painful | Phase 2 | Status: TERMINATED